Cargando…
Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
In liver fibrosis, activated hepatic stellate cells are known to overexpress fibroblast activation protein. Here we report a targeted antifibrotic peptide-delivery system in which fibroblast activation protein, which is overexpressed in fibrotic regions of the liver, liberates the antifibrotic pepti...
Autores principales: | Lee, Jaiwoo, Byun, Junho, Shim, Gayong, Oh, Yu-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938482/ https://www.ncbi.nlm.nih.gov/pubmed/35314685 http://dx.doi.org/10.1038/s41467-022-29186-8 |
Ejemplares similares
-
DNA-based artificial dendritic cells for in situ cytotoxic T cell stimulation and immunotherapy
por: Le, Quoc-Viet, et al.
Publicado: (2021) -
Cell membrane-derived vesicles for delivery of therapeutic agents
por: Le, Quoc-Viet, et al.
Publicado: (2021) -
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
por: Li, Ji-Min, et al.
Publicado: (2023) -
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
por: Jangra, Anshika, et al.
Publicado: (2022) -
In vivo fate and intracellular trafficking of vaccine delivery systems()
por: Lee, Jaiwoo, et al.
Publicado: (2022)